(19)

(11)

EP 4 583 891 A1

(12)

(43) Date of publication: 16.07.2025 Bulletin 2025/29 (21) Application number: 23863913.2 (22) Date of filing: 30.08.2023

(51) International Patent Classification (IPC):  A61K 35/17(2025.01) A61P 35/00(2006.01) A61K 39/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; A61K 35/15; C12N 5/0645; C12N 2506/11; C12N 2501/22; C12N 2501/26; C12N 2501/145; C12N 2501/125; C12N 2501/2303; A61K 40/17; A61K 40/24; A61K 40/4211; A61K 40/31 (86) International application number: PCT/US2023/073151 (87) International publication number: WO 2024/054769 (14.03.2024 Gazette 2024/11)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 07.09.2022 US 202263404486 P (71) Applicant: Deverra Therapeutics Inc. Seattle WA 98102 (US)	(72) Inventors: DELANEY, Colleen Seattle, WA 98102 (US) von EUW, Erika Seattle, WA 98102 (US) KREUSER, Shannon Seattle, WA 98102 (US) STOLTZMAN, Carrie Seattle, WA 98102 (US) BREMPELIS, Katherine Seattle, WA 98102 (US) (74) Representative: FRKelly  Waterways House Grand Canal Quay Dublin D02 PD39 Dublin D02 PD39 (IE)